Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents

British Heart Journal

Volumn 73, Issue 1, 1995, Pages 14-19

  Riesenberg, K ^a   Schlaeffer, F ^a   Katz, A ^a   Levy, R ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Heparin; Neutrophils; Superoxide production; Thrombolytic agents

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEPARIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR; STREPTOKINASE; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; ZYMOSAN;

ARTICLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0028980134     PISSN: 00070769     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.73.1.14     Document Type: Article

References (28)

1. Guerci, A.D.; Gerstenblith, G.; Brinker, J.A.; Gottlieb, S.O.; Weiss, J.L.; Chandra, N.C. A double-blind, placebocontrolled, randomized trial of tPA with subsequent randomization to elective PTCA for acute MI N Engl Med 1988 37 1613
2. Flaherty, J.T.; Weisfeldt, M.L. Reperfusion injury Free Radic BiolMed 1988 10.1016/0891-5849(88)90115-3 5 409
3. Lucchesi, B.R. Myocardial ischemiia, reperfusion and free radical injury. AmJ7 Cardiol 1990 65 14
4. Mehta, J.; Dinerman, J.; Mehta, P.; Saldeen, T.G.P.; Lawson, D.; Donnelly, W.H. Neutrophil function in ischemic heart disease Circulation 1989 10.1161/01.CIR.79.3.549 79 549
5. Przyklenk, K.; Whittaker, P.; Kloner, R.A. In vivo infusion of oxygen free radical substates causes myocardial systolic, but not diastolic dysfunction Am Heart 1990 10.1016/S0002-8703(05)80316-3 119 807
6. Otani, H.; Tanaka, H.; Inoue, T.; Umemoto, M. vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury Circ Res 1984 10.1161/01.RES.55.2.168 55 168
7. Malech, H.L.; Gallin, J.I. Current concepts: immunology neutrophils in human diseases N Engl Med 1987 10.1056/NEJM198709103171107 317 687
8. Babior, B.M. Oxygen-dependent microbial killing by phagocytes-II N Engl Med 1978 10.1056/NEJM197803302981305 298 721
9. Rossi, S.J. The 0,-forming NADPH oxidase of the phagocytes nature: mechanisms and functions Biochim Biophys Acta 1986 10.1016/0304-4173(86)90005-4 853 65
10. Segal, A.W.; West, I.; Wientes, F.; Nugent, J.H.; Chavan, A.J.; Haley, B. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes Biochem 7 1992 781
11. Cross, A.R.; Jones, T.G.; Harper, A.M.; Segal, A.W. Oxidationreduction properties of the cytochrome b found in the plasma-membrane fraction of human neutrophils: a possible oxidase in the respiratory burst Biochem J 1981 599
12. Rotrosen, D.; Yeung, C.L.; Leto, T.L.; Malech, H.L.; Kwong, C.H. Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase Science 1992 10.1126/science.1318579 256 1459
13. Numoi, H.; Rotrosen, D.; Gallin, J.I.; Malech, L. Two forms of autosomal chronic granulomatous disease are deficient in distinct neutrophil cytosol factors Science 1988 10.1126/science.2848319 242 1298
14. Lomax, K.J.; Leto, T.L.; Nunoi, H.; Gallin, J.I.; Malech, H.L. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease Science 1989 10.1126/science.2547247 245 409
15. Abo, A.; Pick, E.; Hall, A.; Toty, N.; Teahan, C.G.; Segal, A.W. Activation of the NADPH oxidase involves the small GTP-binding protein 21racl Nature 1991 10.1038/353668a0 353 668
16. Levy, R.; Malech, H.L.; Rotrosen, D. Production of myeloid cell cytosols functionally and immunochemically deficient in the 47 KDa or 67 KDa NADPH oxidase cytosolic factors Biochem Biophys Res Commun 1990 10.1016/0006-291X(90)90508-K 170 1114
17. Goodman and Gilman's pharmacological basis of therapeutics 8th ed 1991 1313 Gilman, G.
18. Freischlag, J.A.; Colburn, M.D.; Quinones-Baldrich, W.J.; Heparin, Moore W.S.; urokinase and ancrod alter neutrophil function J Vasc Surg 1992 10.1016/0741-5214(92)90164-4 16 565
19. Burke, S.E.; Wright, C.D.; Potoczak, R.E.; Boucher, D.M.; Dodd, G.D.; Taylor, D.G. Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation J Cardiovasc Pharmacol 1992 10.1097/00005344-199210000-00016 20 619
20. Willerson, J.T.; Buja, L.M. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy Am J! Cardiol 1990 10.1016/0002-9149(90)90124-J 65 35
21. Ranjadayalain, K.; Umachandran, V.; Davies, S.W.; Syndercombe-Court, D.; Gutteridge, C.N.; Timmis, A.D. Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury Br HeartJt 1991 10.1136/hrt.66.1.10 66 10
22. Muir, A.L.; Bell, D.-The role of the neutrophil in acute myocardial infarction Health Bull (Edinb) 1989 47 207
23. Bell, D.; Jackson, M.; Jn, Nicoll; Miller, A.; Dawes, J.; Muir, A.L. Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment Br Heart Jf 1990 63 82
24. Goldman, G.; Welbourn, W.; Paterson, I.S.; Fracs, M.B.; Klavsner, J.M.; Lesner, K. Ischemia-induced neutrophil activation and diapedesis is lipoxygenase dependent Surgery 1990 107 428
25. Cambria, R.A.; Anderson, R.J.; Dikdan, G.; Techan, E.P.; Hemandez-Maldonado, J.J.; Hobson, R.W. Leukocyte activation in ischemia-reperfusion injury of skeletal muscle JSurgRes 1991 51 13
26. Odeh, M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome N Engl J Med 1991 10.1056/NEJM199105163242007 324 1417
27. Parini, M.I.; Tringles, M.S.; Tauber, A.I. Identification of distinct activation pathways of the human neutrophil NADPH oxidase JImmunol 1986 137 2925
28. Tarsi-Tsuk, D.; Levy, R. Stimulation of oxidative burst in human monocytes by lipoteichoic acid: involvement of phospholipase A2 J Immunol 1990 144 2665